1,043
Views
6
CrossRef citations to date
0
Altmetric
Research Papers

Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects

, , , , , , & show all
Pages 2142-2147 | Received 20 Aug 2015, Accepted 08 Mar 2016, Published online: 12 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mingjuan Yin, Lingfeng Huang, Yan Zhang, Na Yu, Xiaojia Xu, Yaping Liang & Jindong Ni. (2018) Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Expert Review of Vaccines 17:7, pages 653-663.
Read now
Yang Wang, Jingxin Li, Yuxiao Wang, Wei Gu & Fengcai Zhu. (2018) Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations. Human Vaccines & Immunotherapeutics 14:4, pages 1003-1012.
Read now
Qi Liang, Gui-Fan Li & Feng-Cai Zhu. (2016) Vaccine profile of PPV23: Beijing Minhai Biotech 23-valent pneumococcal vaccine. Expert Review of Vaccines 15:11, pages 1351-1359.
Read now

Articles from other publishers (3)

Shanshan Zhou, Min Lv, Shuang Bai, Weixin Chen, Wei Zhao, Jian Wang, Ao Zhang, Jing Li, Hui Xie, Yanqing Gao, Dongmei Li & Jiang Wu. (2023) Baseline Pneumococcal IgG Levels and Response to 23-Valent Pneumococcal Polysaccharide Vaccine among Adults from Beijing, China. Vaccines 11:12, pages 1780.
Crossref
Redouane Abouqal, Maher Beji, Mohamed Chakroun, Kamal Marhoum El Filali, Jihane Rammaoui & Hela Zaghden. (2022) Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco. Frontiers in Public Health 10.
Crossref
Tom Houben, Inês Magro dos Reis, Yvonne Oligschlaeger, Hellen Steinbusch, Marion J. J. Gijbels, Tim Hendrikx, Christoph J. Binder, David Cassiman, Marit Westerterp, Jos Prickaerts & Ronit Shiri-Sverdlov. (2019) Pneumococcal Immunization Reduces Neurological and Hepatic Symptoms in a Mouse Model for Niemann-Pick Type C1 Disease. Frontiers in Immunology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.